Ensysce Biosciences Inc

NAS:ENSCHealthcarenasdaq_composite

$0.5157+2.55%LiveIn session · ≈ AED 1.89 · Market cap $10.03M · Next earnings Fri 13 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	100.0%	100.0%	−686.1%	−240.1%	−38.6%	−104.8%	—	—
Operating margin	−41.0%	−562.7%	−959.9%	−480.4%	−129.2%	−202.1%	−202.1%	+0.0 pts
Net margin	1.4%	−823.6%	−957.9%	−475.7%	−153.3%	−200.8%	−200.8%	+0.0 pts
EBITDA margin	21.2%	−734.3%	−959.9%	−480.4%	−129.2%	−200.3%	—	—
Return on equity	−0.9%	369.2%	650.8%	3,287.2%	−215.4%	−316.6%	−352.7%	−36.1 pts
Return on assets	16.1%	−177.2%	−410.7%	−391.9%	−142.7%	−136.5%	−136.5%	+0.0 pts
Return on capital employed	24.2%	30,894.5%	676.8%	1,715.2%	−198.5%	−355.0%	—	—
Debt / equity	−0.7×	−2.2×	−1.2×	−2.6×	0.1×	95,437.1×	106,320.5×	+11.4%
Debt / assets	1,213.9%	104.9%	75.3%	31.6%	5.4%	4,115,516.5%	—	—
Interest coverage	−1.6×	−15.3×	−221.2×	−30.3×	−5.2×	−545.7×	—	—
Current ratio	0.0×	1.0×	0.6×	0.7×	2.4×	1.6×	1.6×	+0.0%
Quick ratio	0.0×	1.0×	0.6×	0.7×	2.4×	1.6×	—	—
Cash ratio	0.0×	0.7×	0.3×	0.3×	1.6×	0.9×	0.9×	+0.0%
Asset turnover	11.2×	0.2×	0.4×	0.8×	0.9×	0.7×	—	—
Inventory turnover	—	−0.0×	—	—	—	—	—	—
Receivables turnover	—	8.0×	9.1×	22.9×	42.0×	12.1×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	−3,630.9%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.